Expertise in
2
conditions

Dr. Antonio P. Ciardella

Ophthalmology
Denver Health Hospital Authority
777 Bannock St # 156, 
Denver, CO 
Expertise in
2
conditions
Denver Health Hospital Authority
777 Bannock St # 156, 
Denver, CO 

Overview

Antonio Ciardella is an Ophthalmologist practicing medicine in Denver, Colorado.

Dr. Ciardella is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Retinopathy Pigmentary Mental Retardation, Uveitis, Vitrectomy, and Cataract Removal.

He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 4 clinical trials.

Specialties

Ophthalmology

Licenses

Ophthalmology in CO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

Denver Health Hospital Authority
777 Bannock St # 156, Denver, CO 80204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Observer-masked, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Tetracaine 0.5% Eye Drop as Topical Anestheticsin Phacoemulsification.
A Prospective, Observer-masked, Randomized Clinical Trial to Investigate and Compare the Clinical Efficacy of Chloroprocaine 3% Gel and Tetracaine 0.5% Eye Drop as Topical Anestheticsin Phacoemulsification.
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Enrollment Status: Terminated
Publish Date: July 20, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

52 Total Publications

Retinal microvascular changes in patients with transient ischemic attack and minor ischemic stroke: multimodal insights from the REMARK-TIA study.
Retinal microvascular changes in patients with transient ischemic attack and minor ischemic stroke: multimodal insights from the REMARK-TIA study.
Journal: Journal of neurology
Published: March 01, 2026
Similar Doctors
Expertise in
24
conditions
Dr. Alan G. Palestine
Ophthalmology
Expertise in
24
conditions
Dr. Alan G. Palestine
Ophthalmology
Referral may be required

Office

1675 Aurora Ct, 
Aurora, CO 
 (9.6 miles away)
720-553-2020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alan Palestine is an Ophthalmologist practicing medicine in Aurora, Colorado. Dr. Palestine is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Uveitis, Scleritis, Age-Related Macular Degeneration (ARMD), Cataract Removal, and Vitrectomy. Dr. Palestine is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Office

1675 Aurora Ct, 
Aurora, CO 
 (9.6 miles away)
720-848-5029
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Leonard Seibold is an Ophthalmologist practicing medicine in Aurora, Colorado. Dr. Seibold is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal. Dr. Seibold is currently accepting new patients.

Expertise in
28
conditions
Dr. Marc T. Mathias
Ophthalmology
Expertise in
28
conditions
Dr. Marc T. Mathias
Ophthalmology
Referral may be required

Uchealth Sue Anschutz-Rodgers Eye Center-Lone Tree

9552 Park Meadows Dr Ste 100, 
Lone Tree, CO 
 (14.6 miles away)
720-553-2255
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marc Mathias is an Ophthalmologist practicing medicine in Lone Tree, Colorado. Dr. Mathias is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Hormone Replacement Therapy (HRT). Dr. Mathias is currently accepting new patients.

Frequently Asked Questions about Dr. Antonio P. Ciardella

How do I make an appointment with Dr. Antonio P. Ciardella?

You can book an appointment with Dr. Antonio P. Ciardella by calling their office at 303-436-3448. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Antonio P. Ciardella a top-rated expert for Vitrectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Antonio P. Ciardella is classified as an Advanced expert for Vitrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Antonio P. Ciardella specialize in?

While Dr. Antonio P. Ciardella is a Ophthalmology, they have specific expertise in Vitrectomy, Central Serous Chorioretinopathy, and Retinopathy Pigmentary Mental Retardation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Antonio P. Ciardella participate in research or clinical trials?

Yes. Dr. Antonio P. Ciardella has published 52 articles and abstracts on conditions like Vitrectomy. You can view a list of Dr. Antonio P. Ciardella's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Antonio P. Ciardella accept my insurance?

Dr. Antonio P. Ciardella accepts most major insurance plans, including Medicare. We recommend calling the office directly at 303-436-3448 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ciardella's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile